0 89

Cited 1 times in

Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin-Reply

DC Field Value Language
dc.contributor.author이용준-
dc.contributor.author홍명기-
dc.contributor.author홍성진-
dc.date.accessioned2024-03-22T06:18:34Z-
dc.date.available2024-03-22T06:18:34Z-
dc.date.issued2023-08-
dc.identifier.issn0098-7484-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/198513-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Medical Association-
dc.relation.isPartOfJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHCholesterol, LDL-
dc.subject.MESHCoronary Artery Disease* / drug therapy-
dc.subject.MESHHumans-
dc.subject.MESHHydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use-
dc.subject.MESHPersonality-
dc.subject.MESHRisk Factors-
dc.subject.MESHTreatment Outcome-
dc.titleTreating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin-Reply-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorSung-Jin Hong-
dc.contributor.googleauthorYong-Joon Lee-
dc.contributor.googleauthorMyeong-Ki Hong-
dc.identifier.doi10.1001/jama.2023.9366-
dc.contributor.localIdA02984-
dc.contributor.localIdA04391-
dc.contributor.localIdA04403-
dc.relation.journalcodeJ01196-
dc.identifier.eissn1538-3598-
dc.identifier.pmid37526723-
dc.identifier.urlhttps://jamanetwork.com/journals/jama/fullarticle/2807752-
dc.contributor.alternativeNameLee, Yong-Joon-
dc.contributor.affiliatedAuthor이용준-
dc.contributor.affiliatedAuthor홍명기-
dc.contributor.affiliatedAuthor홍성진-
dc.citation.volume330-
dc.citation.number5-
dc.citation.startPage471-
dc.identifier.bibliographicCitationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.330(5) : 471, 2023-08-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.